Sector Alpha Week of 2026-09-17
Not SEBI Registered !! Not Investment advice !!
Sector Alpha — machine-written from the numbers · Data as of 2026-09-17

Strategy Inc

MSTR
Technology · Software - Application

Strategy Inc's three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it.

Biggest watch item: the price is not yet in a confirmed uptrend — timing risk, not thesis risk.

The price is in a downtrend (2 weeks in) while the P/E sits at the 23rd percentile of its own 3-year range. Underneath, the last four quarters read mixed. What settles it: the next one or two quarters of delivery.

Price
$126
−63.4% 1Y
P/E
8.2×
23rd pctile
of its own 3-year range
Revenue (Jun 26)
$0.1 B
+9.1% YoY
Profit (Jun 26), incl. one-off
$−8.2 B
one-off item — see below
Operating margin
−6,941.7%
−19,696.2 pp YoY
ROE
−64%
FY25
ROIC
−71.8%
vs WACC 21.2% → −93.0 pp
01 · Price story

Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.

Strategy Inc trades at $126, in a downtrend and 2 weeks into that stage. That is −8.1% against its own 200-day average. It sits at 16% of a 52-week range of $82 to $352. On relative strength it has been ahead of the S&P 500 on a trailing-13-week view for 3 straight weeks.

Today the stock is in a downtrend — week 2 of stage 4. At $126 it trades −8.1% versus its 200-day average and sits at 16% of its 52-week range ($82–$352).

Sep 26: $126 Weekly closing price ($) with 50- and 200-day averages; shaded bands mark the price stage (grey base, green advance, amber top, red decline). 3-year window.
−8.1% versus the 200-day line, week 2 of stage 4
Price50-day avg200-day avg
S2S2S1S4$467$349$232$114$0.0$$126$137Sep 23Jun 24Mar 25Dec 25Sep 26
S2S2S1S4$467$349$232$114$0.0$$126$137Sep 23Mar 25Sep 26
Beating or trailing, week by week since 2016 Each cell is one week from 2016 to now (533 weeks): the stock's trailing 13-week return minus the S&P 500's, green ahead / red behind (±25% ramp). Grey cells are the 13-week warm-up or weeks where the S&P 500 reading is not held.
trailing 13-week return vs the S&P 500
Jul 16Sep 26

Against the market, two honest reads. Cumulative: over the last 10.2 years the stock moved +608% while the S&P 500 moved +255% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock has been ahead for 3 straight weeks — the ribbon below is that same metric, week by week.

What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.

02 · Valuation

Valuation P/E is the price of $1 of annual profit: how many dollars the market pays for each dollar the company earns in a year.

Strategy Inc trades at 8.2× P/E, near the bottom of its own range — cheaper only 23% of the time. Its long-run median P/E is 37.8×, measured across 2.8 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.

Today's P/E of 8.2× is near the bottom of its own range — cheaper only 23% of the time, against a long-run median of 37.8× measured over 2.8 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.

P/E 8.2× vs a 37.8× long-run median P/E, weekly (left axis); earnings per share, trailing twelve months, weekly step line (right axis). 2.8-year window; loss-period spikes above 113× shown pinned at the top. The eps (ttm) bars are red where the reading is lower than the quarter before.
near the bottom of its own range — cheaper only 23% of the time
P/EMedianEPS (TTM) (quarterly)
121.9×$23.291.4×$17.461.0×$11.630.5×$5.80.0×$0.0×$8.24×$22Jun 23Dec 23Jun 24Oct 25May 26
121.9×$23.291.4×$17.461.0×$11.630.5×$5.80.0×$0.0×$8.24×$22Jun 23Jun 24May 26
PEG 8.89 PEG ratio per quarter — the P/E divided by the earnings-growth rate. The dashed line marks 1.0: below it the growth is cheap against the multiple, above it the price already prices the growth in. Last 20 quarters; values above 6 pinned at the top.
above 1.0, the multiple already banks the growth
PEGPEG = 1.0
6.4×5.0×3.5×2.0×0.6××6.00×Sep 21Sep 22Dec 23Mar 25Jun 26
6.4×5.0×3.5×2.0×0.6××6.00×Sep 21Dec 23Jun 26
P/E
8.2×
23rd percentile of 3y
PEG
n/m
not derivable — 3-year earnings growth unavailable

The price move, decomposed: over 3y, of the +54.7%/yr price move, ~+317.7%/yr came from earnings growth and ~−263.0 pp from the multiple (compressing). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.

Put together: the multiple is low against its own past, so the story rests on the earnings line underneath it, not the multiple.

03 · Stage: No read

Stage: No read Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).

Strategy Inc reads as no read on its fundamental arc. Under eight usable quarters on the growth trio — not enough history for an honest trajectory read. The read is built from 12 quarters across 2 curves, on partial evidence.

Growth, year by year: revenue +4.3% in FY25 Year-over-year growth per fiscal year, %: revenue (left axis); net profit and EPS (right axis — profit growth swings far wider). Zero line drawn. Turnaround-year spikes shown pinned (▲).
Revenue YoYProfit YoYEPS YoY
5.3%−298.8%1.7%−299.4%−1.9%−300.0%−5.4%−300.6%−9.0%−301.2%%%4.3%−300%FY21FY23FY25
5.3%−298.8%1.7%−299.4%−1.9%−300.0%−5.4%−300.6%−9.0%−301.2%%%4.3%−300%FY21FY23FY25
Three growth curves, twelve quarters Year-on-year growth of trailing-twelve-month revenue (left axis), profit and EPS (right axis — they swing far wider), % at each quarter-end. Base-effect spikes shown pinned (▲). A missing point means that reading is not held for the quarter.
the trajectory the stage is read from · revenue accelerating
RevenueProfitEPS
7.5%−238%3.9%−255%0.2%−271%−3.5%−288%−7.1%−305%%%6.5%−300%−300%Sep 23Dec 24Jun 26
7.5%−238%3.9%−255%0.2%−271%−3.5%−288%−7.1%−305%%%6.5%−300%−300%Sep 23Dec 24Jun 26
ROE Annual readings — the quarterly balance-sheet pieces this curve needs are not held for this stock, so the returns read moves once a year and carries less weight in the call.
the return curve, annual readings
ROE
418%304%190%75%−39%%−7.5%FY22FY23FY25
418%304%190%75%−39%%−7.5%FY22FY23FY25
Revenue growth
Stuck low
latest +6.5% · span −6.1% to +6.5%
ROE
Falling
latest −7.5% · span −7.5%–386.8%

Why it matters: with too little history, an honest page says so instead of guessing a trajectory.

The latest quarter’s profit carries a one-off item larger than the operating base, so the profit curve is shown but does not vote in the stage call.

Return readings here are annual, not quarterly — read as level and direction only; they can confirm the growth curves but never drive the stage on their own.

Fewer than eight usable quarters on the growth curves — this page will not guess a trajectory from a stub of history.

Compound annual growth rate (%) Compound annual growth rate over each window, %. Revenue, profit and EPS from fiscal-year figures; stock price is the price CAGR over the same spans. A dash = that window is not held, or the base was a loss.
1yr3yr5yr10yr
Revenue+4.3%−1.4%
Stock price−63.4%+54.7%+15.5%+22.6%
Revenue YoY (Jun 26)
+9.1%
latest quarter vs a year ago
Revenue 10y
−1.5%
long-run compound pace
04 · 4-Factor Sector Score

4-Factor Sector Score

26.7/100 — rank 26 of 30 in Software - Application · 67% evidence confidence

Strategy Inc scores 26.7 out of 100 against the 30 companies it is compared with in Software - Application, ranking 26. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.

The four contributions add to the total exactly: 4.8 + 5.2 + 10.8 + 5.9 = 26.7. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.

What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.

05 · Revenue

Revenue Revenue is the top line: everything the company billed its customers in the period.

Strategy Inc reported $0.1 B of revenue in the Jun 26 quarter, +9.1% year on year. That is the 2nd straight quarter of year-on-year growth. Over 4 years it has compounded at −1.5% a year. The last full year, FY25, came in at $0.5 B. The last four reported quarters add to $0.5 B.

FY25 revenue came in at $0.5 B (+4.3% on the year), capping 4 years at −1.5% compound. The latest quarter (Jun 26) printed $0.1 B, +9.1% year on year — the 2nd consecutive quarter of year-over-year growth.

FY25 revenue $0.5 B (+4.3% YoY) Revenue bars, $ B (left); YoY growth-% line (right). 5-year window. A bar is red when it is lower than the year before.
−1.5% a year over 4 years
RevenueYoY growth
0.65.3%0.41.7%0.3−1.9%0.1−5.4%0.0−9.0%$ B%$1B4.3%FY21FY23FY25
0.65.3%0.41.7%0.3−1.9%0.1−5.4%0.0−9.0%$ B%$1B4.3%FY21FY23FY25
Jun 26: $0.1 B (+9.1% YoY) Quarterly revenue bars, $ B (left); YoY growth-% line (right). Last 12 quarters. A bar is red when it is lower than the quarter before.
2nd straight quarter of growth
Revenue (quarterly)YoY growth
0.1410%0.115.4%0.070.4%0.04−4.6%0.00−9.7%$ B%$0B9.1%Sep 23Dec 24Jun 26
0.1410%0.115.4%0.070.4%0.04−4.6%0.00−9.7%$ B%$0B9.1%Sep 23Dec 24Jun 26

Pace check: the last four quarters averaged +6.6% growth against the decade's −1.5% — the current year is running faster than its own long-run rate.

Acceleration check: trailing-twelve-month revenue grew +6.5% over the last 4 quarters against +1.0%/yr over the last 8 — accelerating.

06 · Operating margin

Operating margin Operating margin is what is left of every $100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.

Strategy Inc's operating margin is −6,941.7% in the Jun 26 quarter, −19,696.2 percentage points against the same quarter a year ago. Across 5 fiscal years the operating margin has ranged −1,133.3% to −24.0%. The current quarter is running below every full year in that window.

The latest quarter's operating margin is −6,941.7%, −19,696.2 pp against the same quarter a year ago. Across 5 fiscal years the operating margin has ranged −1,133.3%–−24.0%.

🚨 Why the margin moved: operating margin went −19,696.2 pp year on year while gross margin went −6.0 pp — the loss came mostly below the gross line: operating leverage, with costs spread over a bigger revenue base.

FY25: −1,133.3% Operating margin by fiscal year, %, line (left); year-on-year change in the margin, in percentage points, line (right). 5-year window.
within a −1,133.3–−24.0% band over 5 years
operating marginYoY change (pp)
65%309%−257%30%−579%−250%−900%−529%−1,222%−808%%%−1,133.3%−731.1%FY21FY23FY25
65%309%−257%30%−579%−250%−900%−529%−1,222%−808%%%−1,133.3%−731.1%FY21FY23FY25
Jun 26: −6,941.7% operating margin (−19,696.2 pp YoY) Quarterly operating margin, %, line (left); year-on-year change in the margin, in percentage points, line (right). Last 12 quarters. Operating profit as a share of revenue, per quarter.
Operating marginYoY change (pp)
14,938%15,547%7,022%6,083%−894%−3,380%−8,809%−12,843%−16,725%−22,307%%%−6,941.7%−19,696.2%Sep 23Dec 24Jun 26
14,938%15,547%7,022%6,083%−894%−3,380%−8,809%−12,843%−16,725%−22,307%%%−6,941.7%−19,696.2%Sep 23Dec 24Jun 26
07 · Net profit

Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.

Strategy Inc posted a net loss of $8.2 B in the Jun 26 quarter. That quarter carries a one-off item larger than its own revenue, so the year-on-year figure is an artefact rather than a trading result. The full FY25 year was a loss of $3.9 B. That loss is 6,850.0% of the quarter's revenue.

Jun 26 profit was $−8.2 B, −182.0% year on year. On the full year, FY25 printed $−3.9 B (null).

🚨 Read this profit with care: at $−8.2 B it is larger than the whole quarter's revenue of $0.1 B — no operating business earns more than it sells, so this is a one-off item (a debt-to-equity conversion, a tax write-back or an asset sale), not money the business earned. The underlying operations are running at −6,941.7% operating margin; the year-on-year jump and any P/E built on this number are artefacts of the one-off, not a real earnings turn.

FY25 profit $−3.9 B (null YoY) Net profit bars, $ B (left); YoY growth-% line (right). 5-year window. A bar is red when it is lower than the year before.
Net profitYoY growth
0.8−370.9%−0.5−371.5%−1.7−372.1%−3.0−372.7%−4.2−373.3%$ B%$−4B−372.1%FY21FY23FY25
0.8−370.9%−0.5−371.5%−1.7−372.1%−3.0−372.7%−4.2−373.3%$ B%$−4B−372.1%FY21FY23FY25
Jun 26: $−8.2 B (−182.0% YoY) Quarterly net profit bars, $ B (left); YoY growth-% line (right). Last 12 quarters. A bar is red when it is lower than the quarter before.
Net profit (quarterly)YoY growth
12−52%5.3−265%−1.3−478%−7.8−690%−14−903%$ B%$−8B−844.4%Sep 23Dec 24Jun 26
12−52%5.3−265%−1.3−478%−7.8−690%−14−903%$ B%$−8B−844.4%Sep 23Dec 24Jun 26
08 · Cash flow — the router

Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.

Strategy Inc's cash-flow history is too thin to judge how much reported profit converts into cash. In FY25 that was $−0.1 B of operating cash against $−3.9 B of profit. After $0.1 B of capital spending, $−0.1 B was left as free cash. Cash resolution here is annual, because quarterly cash statements are not published.

FY25: operating cash of $−0.1 B against reported profit of $−3.9 B, leaving free cash of $−0.1 B after $0.1 B of capital spending.

Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.

FY25: CFO $−0.1 B vs profit $−3.9 B Operating cash flow and net profit by fiscal year, $ B; the line is free cash flow (CFO minus capital spending). 5-year window, annual resolution.
Operating cashNet profitFree cash
0.8−0.5−1.7−3.0−4.2$ B$−0B$−4B$−0BFY21FY23FY25
0.8−0.5−1.7−3.0−4.2$ B$−0B$−4B$−0BFY21FY23FY25
Jun 26: operating cash $0.0 B Operating cash per quarter, $ B (bars); conversion = operating cash as % of net profit (line, right). Last 12 quarters. Dashed line = 100%.
Operating cash (quarterly)Conversion100%
0.04108%0.0279%0.0050%−0.0321%−0.05−8.0%$ B%$0B0%Sep 23Dec 24Jun 26
0.04108%0.0279%0.0050%−0.0321%−0.05−8.0%$ B%$0B0%Sep 23Dec 24Jun 26

Router verdict: the visible cash user is investment — the next section checks what the spending is buying.

09 · Where the cash goes

Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).

Strategy Inc does not report the debtor, inventory and payable day-counts a cash cycle is built from, so this section reads the investment side instead. Capital spending ran $0.0 B over the last 3 years. Averaged over those years that is 0.0% of FY25 revenue a year.

Working-capital day-counts are not in our numbers for this stock, so this section reads the investment side — where the cash is being put to work.

On the investment side: capital spending of $0.0 B over the last 3 fiscal years.

FY25: capex $0.1 B Capital spending per fiscal year, $ B (bars).
steady investment
Capex
0.050.040.030.010.00$ B$0BFY21FY23FY25
0.050.040.030.010.00$ B$0BFY21FY23FY25
Jun 26: capex $0.0 B in the quarter Capital spending per quarter, $ B (bars, left); free cash flow, $ B (line, right). Last 12 quarters.
Capex (quarterly)Free cash
0.0220.040.0160.010.011−0.010.005−0.030.000−0.06$ B$ B$0B$0BSep 23Dec 24Jun 26
0.0220.040.0160.010.011−0.010.005−0.030.000−0.06$ B$ B$0B$0BSep 23Dec 24Jun 26

The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.

10 · Return on equity

Return on equity Return on equity (ROE) is the profit the business earns on its shareholders’ money. With the full capital-employed split not in our numbers, ROE is the cleanest long ladder we can draw here.

Strategy Inc earns a ROE of −8% in FY25. That is up from a trough of −55% in FY21. Return on invested capital clears the cost of that capital by −93.0 percentage points, so growth here is not yet paying for the capital it uses. The wiring behind it is −802.1% net margin on 0.01× asset turns.

FY25 ROE is −8%, recovered from a FY21 trough of −55% — the full ladder below shows the fall and the climb, undoctored.

🚨 Why the return is what it is — the wiring (FY25): −802.1% net margin × 0.01× asset turns × 1.21× balance-sheet leverage ≈ −9.7% on equity. Margin does its share; leverage is modest — this is an earned return, not a borrowed one.

The capstone test — ROIC − WACC: −71.8% − 21.2% = a −93.0 pp spread. The 21.2% is an estimate of this company's own cost of capital — read the sign and the size of the spread, not the decimals. Negative — growth at these returns destroys value until the returns recover.

FY25: ROE −8% Return on equity by fiscal year, % (line); ROIC by fiscal year, % (line). 5-year window, dips included. Dashed line = the 21.2% cost of capital used on this page.
the climb back from FY21's −55%
ROEROIC (annual)WACC
422%294%166%38%−90%%−7.5%−9.2%FY21FY23FY25
422%294%166%38%−90%%−7.5%−9.2%FY21FY23FY25
Jun 26: ROIC −16.4% (TTM) vs WACC 21.2% Trailing-twelve-month ROIC and ROE, per quarter, %; dashed line = the cost of capital. Last 12 quarters, put on a trailing-twelve-month basis and anchored to the annual figure.
ROIC (TTM)ROE (TTM)WACC
44%20%−3.5%−27%−51%%−16.4%−17.2%Sep 23Dec 24Jun 26
44%20%−3.5%−27%−51%%−16.4%−17.2%Sep 23Dec 24Jun 26
11 · Dividend

Dividend

Strategy Inc pays no dividend. Across the last 12 reported quarters it has declared no dividend per share, so there is no payout history to chart and no yield to quote. Companies at this stage typically reinvest earnings rather than distribute them, which makes the cash-flow and reinvestment sections the place that cash shows up.

Strategy Inc does not currently pay a dividend. Across the last 12 reported quarters the company has declared no dividend per share, so there is no payout history to chart and no yield to quote. Companies at this stage typically reinvest earnings instead of distributing them.

12 · Debt

Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.

Strategy Inc carries total debt of $6.8 B against shareholder equity of $45.3 B as of Jun 26, a debt-to-equity of 0.15 — effectively unlevered. On the annual view that ratio went from 2.28 in FY21 to 0.16 in FY25. The returns elsewhere on this page are therefore earned rather than borrowed.

Jun 26: total debt of $6.8 B against shareholder equity of $45.3 B — a debt-to-equity of 0.15. On the annual view, debt-to-equity went from 2.28 (FY21) to 0.16 (FY25). The returns on this page are earned, not borrowed.

FY25: debt $8.2 B at 0.16× equity Total debt by fiscal year, $ B (bars); debt-to-equity, × (line). 5-year window.
Total debtDebt-to-equity
8.93.0×6.70.4×4.4−2.1×2.2−4.6×0.0−7.1×$ B×$8B0.16×FY21FY23FY25
8.93.0×6.70.4×4.4−2.1×2.2−4.6×0.0−7.1×$ B×$8B0.16×FY21FY23FY25
Jun 26: debt $6.8 B, debt-to-equity 0.15 Total debt per quarter, $ B (bars); debt-to-equity, × (line). Last 12 quarters.
Total debt (quarterly)Debt-to-equity
8.92.9×6.72.1×4.51.4×2.20.7×0.0−0.1×$ B×$7B0.15×Sep 23Dec 24Jun 26
8.92.9×6.72.1×4.51.4×2.20.7×0.0−0.1×$ B×$7B0.15×Sep 23Dec 24Jun 26
13 · Ownership

Ownership There is no quarter-by-quarter holder register to read here, so we read the crowd through short interest — the slice of tradable shares currently sold short, positioned for a fall.

9.0% of Strategy Inc's tradable float is currently sold short — some money is positioned against it. At typical trading volumes those positions would take about 1.3 days to buy back. There is no quarter-by-quarter holder register to read for this filer, so the crowd is read through short interest instead.

The latest reading: 9.0% of the float is sold short, and at typical trading volumes it would take about 1.3 days to buy those positions back. Some money is positioned against it. This is a single point-in-time reading — we do not yet hold its history, so we show no trend chart.

Short interest
9.0%
of the tradable float
Days to cover
1.3
at typical volumes

Why it sits there: who is doing the shorting, and why, does not travel with the number — the level is shown without inventing its story.

14 · Safety line

Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.

Strategy Inc: the Z-score reads 2.99. A Z-score above roughly 3 reads as safe and below roughly 1.8 as the distress zone, so this sits in the grey band between the two. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure.

Why it matters: a Z-score of 2.99 sits in the grey band — neither clearly safe nor clearly distressed.

The safety line in one sentence: the Z-score reads 2.99.

15 · Related companies · Software - Application
CompanyScorePrice stageGrowth & earnings/35Capital efficiency/25Valuation/20Relative strength/20
1Salesforce, Inc.CRM 65.9/100Favorable setup85% evidence BREAKING OUT 18.4/35 Revenue 11.2% · PAT 45% · OPM change -1.4 pp 95% evidence 14.5/25 ROCE 11.4% · OPM 21.4% 76% evidence 15.7/20 P/E 15.6× · PEG 0.26 65% evidence 17.3/20 RS sector 12.1% · RS bench 11.1% · 1Y 1.4%6 of 12 weeks ahead 100% evidence
Exact sum: 18.4 + 14.5 + 15.7 + 17.3 = 65.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
2Manhattan Associates, Inc.MANH 65.1/100Thin evidence · provisional56% evidence BREAKING OUT 17.7/35 Revenue — · PAT — · OPM change -1 pp 39% evidence 20.1/25 ROCE 23.6% · OPM 23% 76% evidence 9.2/20 P/E 39.9× · PEG — 15% evidence 18.1/20 RS sector 20.2% · RS bench 19.7% · 1Y -2.6%10 of 12 weeks ahead 100% evidence
Exact sum: 17.7 + 20.1 + 9.2 + 18.1 = 65.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
3Atlassian CorporationTEAM 64.6/100Mixed-positive evidence61% evidence BREAKING OUT 25.1/35 Revenue 26% · PAT — · OPM change 14 pp 62% evidence 9.5/25 ROCE 7.8% · OPM 11.9% 76% evidence 10.0/20 P/E — · PEG — 0% evidence 20.0/20 RS sector 52.2% · RS bench 48.1% · 1Y 12.6%12 of 12 weeks ahead 100% evidence
Exact sum: 25.1 + 9.5 + 10 + 20 = 64.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
4Fair Isaac CorporationFICO 62.0/100Mixed-positive evidence81% evidence ASLEEP 27.5/35 Revenue 24.1% · PAT 28.4% · OPM change 4.9 pp 83% evidence 21.4/25 ROCE 30.4% · OPM 53.8% 76% evidence 12.3/20 P/E 34.5× · PEG 0.97 65% evidence 0.8/20 RS sector -31.1% · RS bench -31.9% · 1Y -32.9%3 of 12 weeks ahead 100% evidence
Exact sum: 27.5 + 21.4 + 12.3 + 0.8 = 62 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -31.1% and the one-year return is -32.9%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth.
5Autodesk, Inc.ADSK 59.8/100Mixed-positive evidence81% evidence TURNING 28.1/35 Revenue 18.3% · PAT 44.6% · OPM change 13.7 pp 83% evidence 15.1/25 ROCE 8.8% · OPM 28% 76% evidence 13.5/20 P/E 34.5× · PEG 0.74 65% evidence 3.1/20 RS sector -19.1% · RS bench -19.5% · 1Y -31.7%2 of 12 weeks ahead 100% evidence
Exact sum: 28.1 + 15.1 + 13.5 + 3.1 = 59.8 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -19.1% and the one-year return is -31.7%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth.
6Workday, Inc.WDAY 55.8/100Mixed-positive evidence81% evidence BREAKING OUT 25.3/35 Revenue 13.3% · PAT 73.9% · OPM change 11.6 pp 83% evidence 8.8/25 ROCE 3.1% · OPM 13.3% 76% evidence 7.0/20 P/E 38.3× · PEG 2.14 65% evidence 14.7/20 RS sector 3% · RS bench 0.7% · 1Y -19.6%11 of 12 weeks ahead 100% evidence
Exact sum: 25.3 + 8.8 + 7 + 14.7 = 55.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
7SAP SESAP 55.8/100Mixed-positive evidence81% evidence BREAKING OUT 14.6/35 Revenue 6.4% · PAT 20.2% · OPM change -0.9 pp 83% evidence 18.6/25 ROCE 19.7% · OPM 27.6% 76% evidence 12.4/20 P/E 20.1× · PEG 1 65% evidence 10.2/20 RS sector -3.3% · RS bench -4.4% · 1Y -20.1%7 of 12 weeks ahead 100% evidence
Exact sum: 14.6 + 18.6 + 12.4 + 10.2 = 55.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
8Intuit Inc.INTU 55.3/100Mixed-positive evidence81% evidence BREAKING OUT 19.6/35 Revenue 15% · PAT 32.2% · OPM change -1 pp 83% evidence 17.1/25 ROCE 14.9% · OPM 47% 76% evidence 14.1/20 P/E 23.5× · PEG 0.69 65% evidence 4.5/20 RS sector -34.4% · RS bench -36.3% · 1Y -53.8%5 of 12 weeks ahead 100% evidence
Exact sum: 19.6 + 17.1 + 14.1 + 4.5 = 55.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
9DocuSign, Inc.DOCU 54.6/100Mixed-positive evidence71% evidence BREAKING OUT 16.6/35 Revenue 8.4% · PAT -71.5% · OPM change 5.5 pp 83% evidence 10.4/25 ROCE 5.2% · OPM 13.4% 76% evidence 9.8/20 P/E 29.9× · PEG — 15% evidence 17.8/20 RS sector 16.5% · RS bench 15.1% · 1Y -16.8%10 of 12 weeks ahead 100% evidence
Exact sum: 16.6 + 10.4 + 9.8 + 17.8 = 54.6 · Decision use: Price leads the evidence: RS versus the benchmark is 15.1%, but earnings trajectory is weak. Wait for revenue and profit confirmation.
10Zoom Communications, Inc.ZM 53.6/100Mixed-positive evidence81% evidence TURNING 20.8/35 Revenue 5% · PAT 97.5% · OPM change 4.5 pp 83% evidence 11.9/25 ROCE 3.2% · OPM 25.1% 76% evidence 15.8/20 P/E 14.3× · PEG 0.55 65% evidence 5.1/20 RS sector -5.3% · RS bench -3.5% · 1Y 9.2%1 of 12 weeks ahead 100% evidence
Exact sum: 20.8 + 11.9 + 15.8 + 5.1 = 53.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
11Snowflake Inc.SNOW 53.4/100Mixed-positive evidence61% evidence LEADER 23.9/35 Revenue 31.1% · PAT — · OPM change 19.5 pp 62% evidence 4.0/25 ROCE -6.6% · OPM -23.4% 76% evidence 10.0/20 P/E — · PEG — 0% evidence 15.5/20 RS sector 36.7% · RS bench 36.8% · 1Y 43.6%12 of 12 weeks ahead 100% evidence
Exact sum: 23.9 + 4 + 10 + 15.5 = 53.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
12Datadog, Inc.DDOG 53.0/100Mixed-positive evidence71% evidence TURNING 25.0/35 Revenue 31.5% · PAT 42.1% · OPM change 4.8 pp 83% evidence 6.0/25 ROCE 0.1% · OPM 0.5% 76% evidence 8.5/20 P/E 520.7× · PEG — 15% evidence 13.5/20 RS sector 21.5% · RS bench 24.5% · 1Y 66.3%7 of 12 weeks ahead 100% evidence
Exact sum: 25 + 6 + 8.5 + 13.5 = 53 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
13Adobe Inc.ADBE 52.4/100Mixed-positive evidence81% evidence BREAKING OUT 16.1/35 Revenue 11.5% · PAT 5.2% · OPM change -2.1 pp 83% evidence 17.0/25 ROCE 12.1% · OPM 33.8% 76% evidence 12.2/20 P/E 14.8× · PEG 1.25 65% evidence 7.1/20 RS sector -15.6% · RS bench -16.4% · 1Y -31.5%4 of 12 weeks ahead 100% evidence
Exact sum: 16.1 + 17 + 12.2 + 7.1 = 52.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
14Paychex, Inc.PAYX 51.5/100Mixed-positive evidence81% evidence BREAKING OUT 20.8/35 Revenue 16.9% · PAT 6.3% · OPM change 7.5 pp 83% evidence 14.6/25 ROCE 6.4% · OPM 37.7% 76% evidence 6.2/20 P/E 19.8× · PEG 2.83 65% evidence 9.9/20 RS sector 1.6% · RS bench 1.7% · 1Y -10.2%11 of 12 weeks ahead 100% evidence
Exact sum: 20.8 + 14.6 + 6.2 + 9.9 = 51.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
15PTC Inc.PTC 49.9/100Mixed-negative evidence81% evidence TURNING 19.4/35 Revenue 19.5% · PAT 100% · OPM change -4.9 pp 83% evidence 12.6/25 ROCE 3.1% · OPM 27.7% 76% evidence 14.8/20 P/E 11× · PEG 0.81 65% evidence 3.1/20 RS sector -20.8% · RS bench -21.3% · 1Y -36.3%3 of 12 weeks ahead 100% evidence
Exact sum: 19.4 + 12.6 + 14.8 + 3.1 = 49.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
16Automatic Data Processing, Inc.ADP 49.2/100Mixed-negative evidence81% evidence BREAKING OUT 12.9/35 Revenue 6.7% · PAT 8.2% · OPM change -0.5 pp 83% evidence 15.1/25 ROCE 10% · OPM 23% 76% evidence 8.0/20 P/E 20.5× · PEG 2.13 65% evidence 13.2/20 RS sector 4.4% · RS bench 4.5% · 1Y -6.4%12 of 12 weeks ahead 100% evidence
Exact sum: 12.9 + 15.1 + 8 + 13.2 = 49.2 · Decision use: Price leads the evidence: RS versus the benchmark is 4.5%, but earnings trajectory is weak. Wait for revenue and profit confirmation.
17Dynatrace, Inc.DT 49.1/100Thin evidence · provisional56% evidence LEADER 14.7/35 Revenue 18.9% · PAT -66.5% · OPM change -2.6 pp 53% evidence 9.6/25 ROCE 1.3% · OPM 7% 57% evidence 8.9/20 P/E 68.5× · PEG — 15% evidence 15.9/20 RS sector 19.6% · RS bench 19.9% · 1Y 14.1%12 of 12 weeks ahead 100% evidence
Exact sum: 14.7 + 9.6 + 8.9 + 15.9 = 49.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
18SS&C Technologies Holdings, Inc.SSNC 48.8/100Thin evidence · provisional56% evidence BREAKING OUT 18.6/35 Revenue — · PAT — · OPM change 0.6 pp 39% evidence 11.8/25 ROCE 2.8% · OPM 24.2% 76% evidence 10.5/20 P/E 17.8× · PEG — 15% evidence 7.9/20 RS sector -2.4% · RS bench -2.4% · 1Y -9.1%9 of 12 weeks ahead 100% evidence
Exact sum: 18.6 + 11.8 + 10.5 + 7.9 = 48.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
19Roper Technologies, Inc.ROP 47.6/100Mixed-negative evidence81% evidence BREAKING OUT 19.3/35 Revenue 10.9% · PAT 62.8% · OPM change -0.5 pp 83% evidence 11.7/25 ROCE 1.9% · OPM 27.7% 76% evidence 11.7/20 P/E 14× · PEG 1.43 65% evidence 4.9/20 RS sector -10.4% · RS bench -10.9% · 1Y -25.5%8 of 12 weeks ahead 100% evidence
Exact sum: 19.3 + 11.7 + 11.7 + 4.9 = 47.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
20Cadence Design Systems, Inc.CDNS 47.3/100Mixed-negative evidence81% evidence ASLEEP 24.5/35 Revenue 14.7% · PAT 36.2% · OPM change 9.4 pp 83% evidence 13.7/25 ROCE 4.9% · OPM 28.4% 76% evidence 7.0/20 P/E 74.6× · PEG 2.08 65% evidence 2.1/20 RS sector -20.6% · RS bench -19.4% · 1Y -25%2 of 12 weeks ahead 100% evidence
Exact sum: 24.5 + 13.7 + 7 + 2.1 = 47.3 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -20.6% and the one-year return is -25%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth.
21Shopify Inc.SHOP 45.8/100Mixed-negative evidence81% evidence BREAKING OUT 21.8/35 Revenue 32.5% · PAT -17.8% · OPM change 3.4 pp 83% evidence 15.3/25 ROCE 18.2% · OPM 17.6% 76% evidence 3.9/20 P/E 77× · PEG 4.14 65% evidence 4.8/20 RS sector -9.7% · RS bench -10.3% · 1Y -15.2%7 of 12 weeks ahead 100% evidence
Exact sum: 21.8 + 15.3 + 3.9 + 4.8 = 45.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
22Tyler Technologies, Inc.TYL 45.1/100Thin evidence · provisional56% evidence BREAKING OUT 17.1/35 Revenue — · PAT — · OPM change 0.5 pp 39% evidence 10.7/25 ROCE 2.3% · OPM 16.3% 76% evidence 9.3/20 P/E 38.8× · PEG — 15% evidence 8.0/20 RS sector -13.9% · RS bench -15.1% · 1Y -35.2%5 of 12 weeks ahead 100% evidence
Exact sum: 17.1 + 10.7 + 9.3 + 8 = 45.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
23ServiceNow, Inc.NOW 40.0/100Mixed-negative evidence81% evidence BREAKING OUT 13.0/35 Revenue 22.2% · PAT 0.5% · OPM change -7 pp 83% evidence 8.2/25 ROCE 1% · OPM 4.1% 76% evidence 4.0/20 P/E 62× · PEG 4.61 65% evidence 14.8/20 RS sector 3.1% · RS bench 0.9% · 1Y -27.3%10 of 12 weeks ahead 100% evidence
Exact sum: 13 + 8.2 + 4 + 14.8 = 40 · Decision use: Price leads the evidence: RS versus the benchmark is 0.9%, but earnings trajectory is weak. Wait for revenue and profit confirmation.
24Uber Technologies, Inc.UBER 39.6/100Mixed-negative evidence71% evidence ASLEEP 15.8/35 Revenue 16.7% · PAT -23.2% · OPM change 1.8 pp 83% evidence 9.8/25 ROCE 4% · OPM 13.3% 76% evidence 10.6/20 P/E 15.9× · PEG — 15% evidence 3.4/20 RS sector -16.1% · RS bench -16.1% · 1Y -28%2 of 12 weeks ahead 100% evidence
Exact sum: 15.8 + 9.8 + 10.6 + 3.4 = 39.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
25Fiserv, Inc.FISV 38.9/100Mixed-negative evidence81% evidence TURNING 8.0/35 Revenue -1.2% · PAT -33% · OPM change -11.5 pp 83% evidence 10.7/25 ROCE 1.8% · OPM 19.2% 76% evidence 16.0/20 P/E 9.4× · PEG 0.6 65% evidence 4.2/20 RS sector -28% · RS bench -29.4% · 1Y -62.5%0 of 12 weeks ahead 100% evidence
Exact sum: 8 + 10.7 + 16 + 4.2 = 38.9 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity.
26Strategy Incthis pageMSTR 26.7/100Adverse evidence67% evidence TURNING 4.8/35 Revenue 7.8% · PAT -734.6% · OPM change -19064.4 pp 83% evidence 5.2/25 ROCE -14.3% · OPM — 61% evidence 10.8/20 P/E 15× · PEG — 15% evidence 5.9/20 RS sector -25.3% · RS bench -27.3% · 1Y -63.4%2 of 12 weeks ahead 100% evidence
Exact sum: 4.8 + 5.2 + 10.8 + 5.9 = 26.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
27Bending Spoons S.p.A.BSP 49.6/100Thin evidence · provisional18% evidence 17.7/35 Revenue — · PAT — · OPM change 13.5 pp 10% evidence 11.9/25 ROCE 5.5% · OPM 38.8% 57% evidence 10.0/20 P/E — · PEG — 0% evidence 10.0/20 RS sector — · RS bench — · 1Y — 0% evidence
Exact sum: 17.7 + 11.9 + 10 + 10 = 49.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
28Unity Software Inc.U 46.0/100Thin evidence · provisional48% evidence BREAKING OUT 12.0/35 Revenue 7.5% · PAT — · OPM change -39.7 pp 40% evidence 6.2/25 ROCE -6.5% · OPM -69.1% 57% evidence 10.0/20 P/E — · PEG — 0% evidence 17.8/20 RS sector 20.5% · RS bench 18.6% · 1Y -8.5%12 of 12 weeks ahead 100% evidence
Exact sum: 12 + 6.2 + 10 + 17.8 = 46 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
29Quantinuum Inc.QNT 43.7/100Thin evidence · provisional15% evidence ASLEEP 16.4/35 Revenue — · PAT — · OPM change -1316.6 pp 10% evidence 7.3/25 ROCE -9% · OPM — 46% evidence 10.0/20 P/E — · PEG — 0% evidence 10.0/20 RS sector — · RS bench — · 1Y —0 of 3 weeks ahead 0% evidence
Exact sum: 16.4 + 7.3 + 10 + 10 = 43.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
30Figma, Inc.FIG 34.9/100Thin evidence · provisional42% evidence BREAKING OUT 14.7/35 Revenue 41.4% · PAT — · OPM change -58.6 pp 40% evidence 6.0/25 ROCE -9.3% · OPM -41.2% 57% evidence 10.0/20 P/E — · PEG — 0% evidence 4.2/20 RS sector -25.2% · RS bench -28.1% · 1Y -59.4%11 of 12 weeks ahead 70% evidence
Exact sum: 14.7 + 6 + 10 + 4.2 = 34.9 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.

Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led S&P 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.

16 · Frequently asked questions

Frequently asked questions

What is Strategy Inc's stock price today?

Strategy Inc trades at $126, −63.4% over the past year. The company is valued at $48.0 B. The stock sits at 16% of its 52-week range of $82–$352, −8.1% versus its 200-day average. On the tape, the price is in a downtrend, 2 weeks in. — as of 17 September 2026.

What were Strategy Inc's latest quarterly results?

Strategy Inc reported revenue of $0.1 B and a net loss of $8.2 B for the Jun 26 quarter. Revenue rose 9.1% and profit fell 182.0% year on year. Earnings per share were $−24.45. The operating margin was −6,941.7%, 19,696.2 pp lower than a year earlier. — as of 17 September 2026.

What is Strategy Inc's revenue?

Strategy Inc reported revenue of $0.1 B in the Jun 26 quarter, +9.1% year on year. For the full FY25 fiscal year, revenue was $0.5 B (+4.3%). Over the last 4 years revenue compounded at −1.5% a year. — as of 17 September 2026.

What is Strategy Inc's profit?

Strategy Inc earned $−8.2 B of net profit in the Jun 26 quarter, −182.0% year on year. Full-year FY25 profit was $−3.9 B. The operating margin ran −6,941.7% in the latest quarter. — as of 17 September 2026.

What is Strategy Inc's market cap?

Strategy Inc's market capitalisation is $48.0 B at a stock price of $126. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 17 September 2026.

What is Strategy Inc's P/E ratio?

Strategy Inc trades at a P/E of 8.2×, at the 23rd percentile of its own 3-year range, against a long-run median of 37.8×. This is a comparison with the stock's own history, not a value call — as of 17 September 2026.

Does Strategy Inc pay a dividend?

No — Strategy Inc has declared no dividend per share in any of its last 12 reported quarters, so there is no payout history and no yield to quote. That is a reading of the filed statements, not an estimate. — as of 17 September 2026.

Is Strategy Inc overvalued?

On its own history, Strategy Inc looks cheap: its P/E of 8.2× has been cheaper only 23% of the time in 3 years (long-run median 37.8×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 17 September 2026.

Is Strategy Inc growing?

The picture is mixed for Strategy Inc: latest-quarter revenue +9.1% year on year, profit −182.0%, and the margin −19,696.2 pp at −6,941.7%. The earnings engine currently reads: mixed — as of 17 September 2026.

How is Strategy Inc performing?

Strategy Inc is in a downtrend, 2 weeks in. Its latest quarter's revenue rose 9.1% and profit fell 182.0% year on year. Against the S&P 500 it has been ahead on a trailing-13-week view for 3 weeks. This describes what the data did, not a rating. — as of 17 September 2026.

Is Strategy Inc in an uptrend?

No — the price is in a downtrend (week 2 of stage 4), trading −8.1% versus its 200-day average and at 16% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 17 September 2026.

Is Strategy Inc beating the market?

On recent form, yes — Strategy Inc has been ahead of the S&P 500 on a trailing-13-week view for 3 straight weeks, the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.2 years the stock moved +608% against the S&P 500's +255% — ahead of the index over the full window. — as of 17 September 2026.

Will Strategy Inc's stock price go up?

This page publishes no price forecast for Strategy Inc. What it measures instead: the stock price is $126, the price is in a downtrend 2 weeks in. Its P/E of 8.2× sits at the 23rd percentile of its own 3-year range. Direction is not something this site claims to know. — as of 17 September 2026.

Is the market betting against Strategy Inc?

Somewhat — short interest is 9.0% of Strategy Inc's tradable float, about 1.3 days to cover at typical volumes. A moderate reading: some money is positioned against it. With no quarter-by-quarter holder register here, short interest is the cleanest crowd read we hold — as of 17 September 2026.

Does Strategy Inc have too much debt?

No — Strategy Inc's debt-to-equity is 0.15. A year-by-year borrowings ladder is not in our numbers for this stock, so the latest reading is the cleanest hold. The returns on this page are earned, not borrowed — as of 17 September 2026.

What is Strategy Inc's capex?

Strategy Inc spent $0.0 B on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY25 alone that was $0.1 B. — as of 17 September 2026.

What is Strategy Inc's cash flow?

Strategy Inc consumed $0.1 B of operating cash in FY25 — cash flowed out rather than in (free cash flow: $−0.1 B). Reported profit that year was $−3.9 B, so operating cash ran ahead of profit. — as of 17 September 2026.

How financially safe is Strategy Inc?

On the balance sheet, the Z-score reads 2.99 — above roughly 3 is safe, below roughly 1.8 is the distress zone. That is in the grey band — neither clearly safe nor clearly distressed. — as of 17 September 2026.

Where is Strategy Inc in its business cycle?

Strategy Inc's FY25 operating margin was −1,133.3%, against a 5-year band of −1,133.3%–−24.0%: the low end of its own band, which is where recoveries start when they come. The latest quarter ran −6,941.7%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 17 September 2026.

What could break the Strategy Inc story?

Biggest watch item: the price is not yet in a confirmed uptrend — timing risk, not thesis risk. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 17 September 2026.

Is Strategy Inc a stock worth studying right now?

This is not investment advice. The machine read: Strategy Inc's three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it. The sharpest open question: the next one or two quarters of delivery. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 17 September 2026.

Sector Alpha — machine-written from the numbers · Data as of 2026-09-17. Every chart on this page is drawn by deterministic code from the raw series — no forecasts, no price opinions, and nothing here is investment advice.

Not SEBI Registered !! Not Investment advice !!

Chat with this pageChat with pageChatChatGPTClaudePerplexityGoogle AI